We are live on
!
Find out more
JO
John Overdeck Two Sigma Investments
AUM
$138B
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter
Est. Return
-4.03%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$29.4B
AUM Growth
-$873M
(-2.9%)
Cap. Flow
+$534M
Cap. Flow
% of AUM
1.81%
Top 10 Holdings %
Top 10 Hldgs %
8.87%
Holding
3,036
New
582
Increased
766
Reduced
960
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$244M |
| 2 |
Enphase Energy
ENPH
|
+$229M |
| 3 |
GSK
GSK
|
+$223M |
| 4 |
Accenture
ACN
|
+$209M |
| 5 |
Citigroup
C
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$294M |
| 2 |
Amazon
AMZN
|
+$272M |
| 3 |
PayPal
PYPL
|
+$271M |
| 4 |
Bank of America
BAC
|
+$225M |
| 5 |
AVGOP
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 13.7% |
| 3 | Financials | 9.76% |
| 4 | Industrials | 8.72% |
| 5 | Consumer Discretionary | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Vanda Pharmaceuticals
VNDA
$322M
| $3.52M | 0.01% |
356,524
-52,844
| -13% | -$558K |
|
|
AAT
877
American Assets Trust
AAT
$1.41B
| $3.51M | 0.01% |
136,620
+50,735
| +59% | +$1.45M |
|
|
SYNH
878
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $3.51M | 0.01% |
74,452
+44,703
| +150% | +$2.89M |
|
879
Brookfield Infrastructure Partners
BIP
$17.7B
| $3.5M | 0.01% |
97,547
-2,772
| -3% | -$111K |
|
880
Supernus Pharmaceuticals
SUPN
$2.62B
| $3.49M | 0.01% |
+103,048
| New | +$3.35M |
|
881
Tapestry
TPR
$26.4B
| $3.49M | 0.01% |
122,681
-981,973
| -89% | -$32.8M |
|
882
Kura Oncology
KURA
$1.1B
| $3.48M | 0.01% |
255,139
+163,239
| +178% | +$2.52M |
|
883
Tetra Tech
TTEK
$9.44B
| $3.48M | 0.01% |
+135,185
| New | +$3.78M |
|
884
Metropolitan Bank Holding Corp
MCB
$1.12B
| $3.47M | 0.01% |
53,929
+17,748
| +49% | +$1.26M |
|
885
Grupo Cibest SA
CIB
$24B
| $3.46M | 0.01% |
141,991
-1,403
| -1% | -$40.5K |
|
886
Transmedics
TMDX
$3.25B
| $3.45M | 0.01% |
+82,686
| New | +$3.6M |
|
887
InterDigital
IDCC
$8.8B
| $3.45M | 0.01% |
85,279
-132,469
| -61% | -$7.14M |
|
888
McGrath RentCorp
MGRC
$2.85B
| $3.45M | 0.01% |
41,087
-8,864
| -18% | -$736K |
|
889
Hexcel
HXL
$7B
| $3.44M | 0.01% |
+66,584
| New | +$3.88M |
|
890
Vericel Corp
VCEL
$2.17B
| $3.44M | 0.01% |
148,227
-39,491
| -21% | -$1.08M |
|
891
OptimizeRx
OPRX
$144M
| $3.43M | 0.01% |
231,409
+206,308
| +822% | +$4.08M |
|
892
Trupanion
TRUP
$1.39B
| $3.42M | 0.01% |
57,531
+38,812
| +207% | +$2.61M |
|
|
SWT
893
DELISTED
Stanley Black & Decker, Inc.
SWT
| $3.42M | 0.01% |
69,324
+50,000
| +259% | +$3.1M |
|
894
FIGS
FIGS
$2.53B
| $3.42M | 0.01% |
414,051
-1,217,042
| -75% | -$12.9M |
|
895
Federated Hermes
FHI
$4.83B
| $3.42M | 0.01% |
+103,102
| New | +$3.52M |
|
|
SHYF
896
DELISTED
The Shyft Group
SHYF
| $3.41M | 0.01% |
167,094
-20,517
| -11% | -$479K |
|
897
Evolent Health
EVH
$534M
| $3.41M | 0.01% |
94,800
+8,120
| +9% | +$286K |
|
|
NGM
898
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $3.4M | 0.01% |
259,940
+91,020
| +54% | +$1.38M |
|
|
STEL
899
DELISTED
Stellar Bancorp
STEL
| $3.39M | 0.01% |
115,915
+72,710
| +168% | +$2.19M |
|
900
Tenaris
TS
$27B
| $3.39M | 0.01% |
131,233
-23,301
| -15% | -$616K |
|
Similar funds
John Overdeck's Q3 2022 Portfolio in Review
As of Q3 2022, John Overdeck held 3,036 positions worth $29.4B, down 2.9% from $30.3B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
John Overdeck's Q3 2022 filing shows 582 new, 766 increased, 960 reduced and 600 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,198,196 shares worth $210M. The largest sale was Netflix, an estimated $294M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- John Overdeck's largest Q3 2022 buy was Alphabet (Google) Class A: 2,198,196 shares worth $210M.
- John Overdeck added most to GSK in Q3 2022, an estimated $223M increase.
- John Overdeck's biggest Q3 2022 reduction was Netflix, cutting an estimated $294M.
- John Overdeck fully exited Bank of America in Q3 2022, selling an estimated $225M.
- John Overdeck's ten largest holdings make up 8.9% of its $29.4B portfolio in Q3 2022.
- John Overdeck opened 582 new positions and closed 600 in Q3 2022.
- John Overdeck's portfolio value fell 2.9% quarter-over-quarter to $29.4B.
Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.